← Browse by Condition
Medical Condition
major depressive disorder mdd
Total Trials
14
Recruiting Now
14
Trial Phases
Phase 3, Phase 4, Phase 2
ClinicalMetric tracks all active clinical trials for major depressive disorder mdd sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — major depressive disorder mdd Clinical Trials
How many clinical trials are currently recruiting for major depressive disorder mdd?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for major depressive disorder mdd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for major depressive disorder mdd?
major depressive disorder mdd research spans Phase 2 (1 trial), Phase 3 (2 trials), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a major depressive disorder mdd clinical trial?
Eligibility criteria for major depressive disorder mdd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 2
Phase 4 2
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07230990
Recruiting
Mechanisms Of Orbitofrontal Stimulation in Depression
Enrollment
80 pts
Location
United States
Sponsor
Subha Subramanian
NCT06793397 Phase 3
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Enrollment
330 pts
Location
United States, Austr...
Sponsor
Cybin IRL Limited
NCT07025720
Recruiting
Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk
Enrollment
25 pts
Location
United States
Sponsor
University of California, Davi...
NCT07324070
Recruiting
Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression
Enrollment
50 pts
Location
Czechia
Sponsor
Charles University, Czech Repu...
NCT07095205 Phase 4
Recruiting
PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.
Enrollment
14 pts
Location
United States
Sponsor
Stony Brook University
NCT07396272 Phase 2
Recruiting
A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression
Enrollment
12 pts
Location
Sweden
Sponsor
Daniel Lindqvist
NCT06972368
Recruiting
Home-Based tDCS for Depression in BPD
Enrollment
60 pts
Location
Canada
Sponsor
Ciusss de L'Est de l'Île de Mo...
NCT07009223
Recruiting
Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice
Enrollment
120 pts
Location
Italy
Sponsor
IRCCS Centro San Giovanni di D...
NCT07115628
Recruiting
Accelerated TMS for Treatment-Resistant ECT
Enrollment
200 pts
Location
Belgium
Sponsor
Universitair Ziekenhuis Brusse...
NCT06728774
Recruiting
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
Enrollment
24 pts
Location
United States
Sponsor
Portland VA Medical Center
NCT07217444
Recruiting
Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation
Enrollment
60 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
NCT07076342 Phase 4
Recruiting
The Role of mGluR5 in CBT-I
Enrollment
42 pts
Location
United States
Sponsor
Stony Brook University
NCT06958692 Phase 3
Recruiting
A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder
Enrollment
388 pts
Location
China
Sponsor
CSPC Ouyi Pharmaceutical Co., ...
NCT07402356
Recruiting
VR Pupillometry in Cognitive Impairment
Enrollment
140 pts
Location
Germany
Sponsor
Max-Planck-Institute of Psychi...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology